NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,023 Cr | ₹1,477 Cr | ₹1,559 Cr | ₹1,191 Cr | ₹951 Cr |
What is the latest Revenue of NEULAND LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,023 Cr |
| Mar2025 | ₹1,477 Cr |
| Mar2024 | ₹1,559 Cr |
| Mar2023 | ₹1,191 Cr |
| Mar2022 | ₹951 Cr |
How is Revenue of NEULAND LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,023 Cr | 36.98 | |
| Mar2025 | ₹1,477 Cr | -5.24 | |
| Mar2024 | ₹1,559 Cr | 30.84 | |
| Mar2023 | ₹1,191 Cr | 25.25 | |
| Mar2022 | ₹951 Cr | - | |
Compare Revenue of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹27,505.7 Cr | 0.1% | 11.2% | 23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.1% |
11.2% |
23.1% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses